These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 23415508)

  • 21. Probity gone nuts.
    Nat Biotechnol; 2007 May; 25(5):483. PubMed ID: 17483818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A turning point for conflicts of interest: the controversy over the National Academy of Sciences' first conflicts of interest disclosure policy.
    Parascandola M
    J Clin Oncol; 2007 Aug; 25(24):3774-9. PubMed ID: 17704427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. US dietary committee criticised for ties to industry.
    Nelson R
    Lancet; 2003 Sep; 362(9386):808. PubMed ID: 13678891
    [No Abstract]   [Full Text] [Related]  

  • 24. The troublesome semantics of conflict of interest.
    Friedman PJ
    Ethics Behav; 1992; 2(4):245-51. PubMed ID: 11651613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Health impact assessment of agriculture and food policies: lessons learnt from the Republic of Slovenia.
    Lock K; Gabrijelcic-Blenkus M; Martuzzi M; Otorepec P; Wallace P; Dora C; Robertson A; Zakotnic JM
    Bull World Health Organ; 2003; 81(6):391-8. PubMed ID: 12894321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conflicts cause FDA to review advisory committees.
    Kondro W
    CMAJ; 2006 Jul; 175(1):23. PubMed ID: 16818900
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical trials integrity: a CRO perspective.
    Beach JE
    Account Res; 2001; 8(3):245-60. PubMed ID: 12481762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. When is a point of view a conflict of interest?
    Lenzer J
    BMJ; 2016 Nov; 355():i6194. PubMed ID: 27881367
    [No Abstract]   [Full Text] [Related]  

  • 29. Naturally occurring asbestos: a recurring public policy challenge.
    Lee RJ; Strohmeier BR; Bunker KL; Van Orden DR
    J Hazard Mater; 2008 May; 153(1-2):1-21. PubMed ID: 18180100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Responses to the Gagnon report and REBs.
    Gagnon D;
    NCBHR Commun; 1993; 4(2):3-5. PubMed ID: 11652886
    [No Abstract]   [Full Text] [Related]  

  • 31. The Deschamps Report: controls for clinical research in Quebec.
    Miller J
    J Int Bioethique; 1997; 8(1-2):79-85. PubMed ID: 11655382
    [No Abstract]   [Full Text] [Related]  

  • 32. IRBs and pharmaceutical company funding of research.
    Jellinek MS; Levine RJ
    IRB; 1982 Oct; 4(8):9-10. PubMed ID: 11651693
    [No Abstract]   [Full Text] [Related]  

  • 33. Ethics review slams government panels over conflicts of interest.
    Marris E
    Nature; 2004 Sep; 431(7004):3. PubMed ID: 15343294
    [No Abstract]   [Full Text] [Related]  

  • 34. Trends in gene therapy regulation.
    Lecomte V; Taylor A
    Gene Ther; 1997 Feb; 4(2):77-8. PubMed ID: 11644906
    [No Abstract]   [Full Text] [Related]  

  • 35. Institutional review boards should not have primary conflict of interest duty.
    Maloney DM
    Hum Res Rep; 2001 Aug; 16(8):1-2. PubMed ID: 11833564
    [No Abstract]   [Full Text] [Related]  

  • 36. Experts suggest U.S. sharply limit breast implants.
    Hilts PJ
    N Y Times Web; 1992 Feb; ():A1, A16. PubMed ID: 11646915
    [No Abstract]   [Full Text] [Related]  

  • 37. RU 486 and the politics of drug regulation in the United States and France.
    Kramnick RK
    Cornell Int Law J; 1992; 25():667-718. PubMed ID: 11656340
    [No Abstract]   [Full Text] [Related]  

  • 38. Impact of the Human Genome Project at the interface between patent and FDA laws.
    Cunningham BC
    Risk; 1996; 7(3):253-66. PubMed ID: 11655078
    [No Abstract]   [Full Text] [Related]  

  • 39. Beyond localism: a proposal for a National Research Review Board.
    Levine C; Caplan AL
    IRB; 1986; 8(2):7-9. PubMed ID: 11649751
    [No Abstract]   [Full Text] [Related]  

  • 40. Financial conflict of interest in medical research: overview and analysis of federal and state controls.
    Henderson JA; Smith JJ
    Food Drug Law J; 2002; 57(3):445-56. PubMed ID: 12710405
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.